Vasopharm’s ronopterin fails in traumatic brain injury trial
The trial’s primary and secondary endpoints enable analysis of the path of neurologic recovery in the first six months after…

The trial’s primary and secondary endpoints enable analysis of the path of neurologic recovery in the first six months after…
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct a Phase II clinical trial…
Novo Nordisk has reported positive data from the Phase II REAL 3 clinical trial of somapacitan in children with growth…
Researchers from Austrian university TU Wien and international pharmaceutical company Sandoz have developed a computer simulation that replicates the growth…
Thank you for subscribing to Clinical Trials Arena